Stay updated on Selonsertib for NASH F3 Fibrosis Clinical Trial

Sign up to get notified when there's something new on the Selonsertib for NASH F3 Fibrosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Selonsertib for NASH F3 Fibrosis Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.3 to v3.5.4. A new Revision: v3.5.4 entry was added and the previous Revision: v3.5.3 entry was removed, representing an update to the site’s release version.
    Difference
    0.0%
    Check dated 2026-05-16T10:04:12.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    Taoyuan District, Taiwan, 33305 was removed and Taoyuan, Taiwan, 33305 was added in the locations section, changing the named locality while keeping the same postal code. This reflects a naming update to how the site is identified geographically.
    Difference
    0.0%
    Check dated 2026-05-02T09:30:28.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The page’s display/version footer was updated from Revision v3.5.2 to Revision v3.5.3, indicating a minor site software release without altering the underlying study record content.
    Difference
    0.0%
    Check dated 2026-04-25T06:14:30.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Removed Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-18T03:52:55.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added. Several glossary/related items were removed, including Non-alcoholic fatty liver disease, MedlinePlus Genetics, and Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-20T07:12:10.000Z thumbnail image
  9. Check
    82 days ago
    Change Detected
    Summary
    Added related topics: Nonalcoholic fatty liver disease and MedlinePlus Genetics to the study page.
    Difference
    0.0%
    Check dated 2026-03-13T01:30:12.000Z thumbnail image

Stay in the know with updates to Selonsertib for NASH F3 Fibrosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Selonsertib for NASH F3 Fibrosis Clinical Trial page.